4 心血管血管血管学会と介入 ショックステージの定義: 遡及的研究
Tobias Becher1,2,3, Leonie Hahn1,2,3, Markward Britsch1,2,3,4,5,6,7
1Cardiology, Haemostaseology, and Medical Intensive Care, Medical Centre Mannheim, Medical Faculty Mannheim Heidelberg University Heidelberg Germany.
Journal of the American Heart Association
|August 23, 2025
まとめ
Society for Cardiovascular Angiography and Interventions (SCAI) の SHOCK ステージ分類の異なる定義は,心血管性ショック (CS) を評価する上で適度な合意を示した. すべてのフレームワークは重症度によって患者を効果的に層分けし,入院死亡の予測性能も同様でした.
科学分野:
- 心臓病科
- 臨床研究
背景:
- 心臓発作性ショック (CS) は高い死亡率で重大な課題であり,正確な診断ツールが必要です.
- 心血管血管血管学協会 (SCAI) のSHOCKステージ分類は,CSの評価と結果予測の重要なツールです.
研究 の 目的:
- SCAI SHOCK段階の判定に対するパラメータの定義の違いの影響を評価する.
- 定義の変動がCS評価と患者層分化にどのように影響するか評価する.
主な方法:
- 2018年1月から2022年6月までの間にCSと診断された1281人の患者の遡及分析.
- SCAI SHOCKの段階の割り当ては,4つの別々の公開された分類枠組みに基づいています.
- ステージ分布,結果,分類一致性,予測性能の評価
主要な成果:
- 4つのSCAI SHOCK分類フレームワークで高い一致 (98. 2%) が観察されました.
- ステージの割り当てと死亡率の変動にもかかわらず,全体的な分類合意 (ケンドールのW=0. 70) は中等から強いものであった.
- フレームワークの間で入院死亡率の予測性能において有意な差異は検出されなかった.
結論:
- この研究は,異なるSCAI SHOCKステージ分類フレームワークの中等から強い一致性と比較可能な予後性能を確認した.
- すべてのフレームワークは,臨床的重症に基づいて患者を順位付けし,CS評価における有用性を強調しました.
- SCAI SHOCK ステージ分類システムの標準化は,一貫した遡及研究割り当てのために推奨されます.
さらに関連する動画
関連する概念動画
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
119
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
119
01:30Acute Coronary Syndrome III: Diagnostic Studies
23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
01:30Heart Failure IV: Classification and Diagnostic Evaluation
32
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
32